1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)2D3 in NSCLC Treatment

Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing Wolf–Hirschhorn syndrome candidate 1/Twist pathway

(2013) Chih-Hsin Kuo et al.   CARCINOGENESIS

Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes

(2013) Roberto Gomez-Casal et al.   Molecular Cancer

Down-Regulation of Vitamin D Receptor in Mammospheres: Implications for Vitamin D Resistance in Breast Cancer and Potential for Combination Therapy

(2013) Shehla Pervin et al.   PLoS One

The role of epithelial–mesenchymal transition programming in invasion and metastasis: a clinical perspective

(2013) Chad Creighton et al.   Cancer Management and Research

Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1α,25-dihydroxycholecalciferol

(2012) Yingyu Ma et al.   CANCER

Vitamin D has wide regulatory effects on histone demethylase genes

(2012) Fábio Pereira et al.   CELL CYCLE

An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

(2012) L. A. Byers et al.   CLINICAL CANCER RESEARCH

1,25-Dihydroxyvitamin D3 Suppresses Telomerase Expression and Human Cancer Growth through MicroRNA-498

(2012) Ravi Kasiappan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line

(2012) Jin Ren et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Differential response to 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) in non-small cell lung cancer cells with distinct oncogene mutations

(2012) Qiuhong Zhang et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Characterization of vitamin D receptor (VDR) in lung adenocarcinoma

(2012) So Hee Kim et al.   LUNG CANCER

CYP24 inhibition preserves 1α,25-dihydroxyvitamin D3 anti-proliferative signaling in lung cancer cells

(2012) Qiuhong Zhang et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Research Resource: Diagnostic and Therapeutic Potential of Nuclear Receptor Expression in Lung Cancer

(2012) Yangsik Jeong et al.   MOLECULAR ENDOCRINOLOGY

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

(2012) Zhenfeng Zhang et al.   NATURE GENETICS

KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells

(2011) Fábio Pereira et al.   HUMAN MOLECULAR GENETICS

Role of Vitamin D Receptor in the Antiproliferative Effects of Calcitriol in Tumor-Derived Endothelial Cells and Tumor Angiogenesis In vivo

(2009) I. Chung et al.   CANCER RESEARCH

TGF-β-induced epithelial to mesenchymal transition

(2009) Jian Xu et al.   CELL RESEARCH

Vitamin D inhibition of pro-fibrotic effects of transforming growth factor β1 in lung fibroblasts and epithelial cells

(2009) Allan M. Ramirez et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

DICKKOPF-4 is induced by TCF/β-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1α,25-dihydroxyvitamin D3

(2008) N Pendás-Franco et al.   ONCOGENE